Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, August 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 195 articles:
HTML format


 

Single Articles

  1. SARAJI A, Sydykov A, Schafer K, Garcia-Castro CF, et al
    PINK1-mediated Mitophagy Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2021;65:226-228.
    PubMed    


  2. SUGARMAN J, Weatherald J
    Management of Pulmonary Hypertension Due to Chronic Lung Disease.
    Methodist Debakey Cardiovasc J. 2021;17:124-133.
    PubMed    
    Abstract available

  3. MACERA F, Vachiery JL
    Management of Pulmonary Hypertension in Left Heart Disease.
    Methodist Debakey Cardiovasc J. 2021;17:115-123.
    PubMed    
    Abstract available

  4. TEA I, Hussain I
    Under Pressure: Right Heart Catheterization and Provocative Testing for Diagnosing Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2021;17:92-100.
    PubMed    
    Abstract available

  5. SARAH B, Ashrith G, Sandeep S
    Evaluation, Diagnosis, and Classification of Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2021;17:86-91.
    PubMed    
    Abstract available

  6. GUHA A, Sahay S
    Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2021;17:84-85.
    PubMed    


  7. SAHAY S, Guha A
    Drs. Sandeep Sahay and Ashrith Guha Lead Issue on Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2021;17:83.
    PubMed    


  8. ENOMOTO N, Suzuki S, Hozumi H, Karayama M, et al
    Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
    Sci Rep. 2021;11:15502.
    PubMed    
    Abstract available

  9. VILELA VS, Dias MM, Salgado AA, da Silva BRA, et al
    Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    BMC Pulm Med. 2021;21:251.
    PubMed    
    Abstract available

  10. MALLOY KW, Austin ED
    Pulmonary Hypertension in the child with Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2021 Jul 29. doi: 10.1002/ppul.25602.
    PubMed    
    Abstract available

  11. LIU T, Xie L, Liu HM, Liu B, et al
    [The Effects of Ginsenoside Compound K on PDGF-BB-Induced PASMCs Proliferation and Phenotypic Conversion of Pulmonary Arterial Smooth Muscle Cells].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:643-648.
    PubMed    
    Abstract available

  12. AMODEO I, Pesenti N, Raffaeli G, Macchini F, et al
    NeoAPACHE II. Relationship Between Radiographic Pulmonary Area and Pulmonary Hypertension, Mortality, and Hernia Recurrence in Newborns With CDH.
    Front Pediatr. 2021;9:692210.
    PubMed    
    Abstract available

  13. LLOJI A, Hooda U, Sreenivasan J, Malekan R, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Am J Cardiovasc Dis. 2021;11:330-347.
    PubMed    
    Abstract available

  14. FATHALA A, Aldurabi A
    Frequency of computed tomography abnormalities in patients with chronic thromboembolic pulmonary hypertension: a comparative study between lung perfusion scan and computed tomography pulmonary angiography.
    Multidiscip Respir Med. 2021;16:753.
    PubMed    
    Abstract available

  15. MCHUGH S, Vanchiere C, Oliveros E, Islam S, et al
    Malignancy-Related Pulmonary Hypertension Presenting as a Pulmonary Veno-Occlusive-Like Syndrome: A Single-Center Case Series.
    JACC Case Rep. 2021;3:1044-1050.
    PubMed    
    Abstract available

  16. SCHWARTZ BP, Tracy P, Hon S, Farber HW, et al
    Pulmonary Tumor Thrombotic Microangiopathy as a Cause of Pulmonary Hypertension.
    JACC Case Rep. 2021;3:1029-1031.
    PubMed    
    Abstract available

  17. TIAN Q, Fan X, Ma J, Li D, et al
    Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
    FASEB J. 2021;35:e21822.
    PubMed    
    Abstract available

  18. SHARIYA AM, Martynyuk TV, Ternovoy SK, Shariya MA, et al
    [Possibilities of Magnetic Resonance Tomography in Diagnosis of Pulmonary Arterial Hypertension].
    Kardiologiia. 2021;61:97-104.
    PubMed    
    Abstract available

  19. KAMENSKAYA OV, Loginova IY, Klinkova AS, Lomivorotov VV, et al
    Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
    Kardiologiia. 2021;61:28-34.
    PubMed    
    Abstract available

  20. HAMUD A, Brezins M, Shturman A, Abramovich A, et al
    Right coronary artery diastolic perfusion pressure on outcome of patients with left heart failure and pulmonary hypertension.
    ESC Heart Fail. 2021 Jul 23. doi: 10.1002/ehf2.13469.
    PubMed    
    Abstract available

  21. BOON GJAM, Jairam PM, Groot GMC, van Rooden CJ, et al
    Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise.
    Eur J Intern Med. 2021 Jul 19. pii: S0953-6205(21)00243.
    PubMed    
    Abstract available

  22. KAWADE A, Yamamura A, Fujiwara M, Kobayashi S, et al
    Comparative analysis of age in monocrotaline-induced pulmonary hypertensive rats.
    J Pharmacol Sci. 2021;147:81-85.
    PubMed    
    Abstract available

  23. MAHDAVI M, Asadian S, Rezaeian N, Asl Fallah S, et al
    Chronic thromboembolic pulmonary hypertension secondary to Behcet's disease: an extremely rare pediatric case.
    Cardiol Young. 2021 Jul 23:1-5. doi: 10.1017/S1047951121002730.
    PubMed    
    Abstract available

  24. YOSHIDA T, Matsuura K, Seijirow G, Uemura A, et al
    Non-invasive Assessment of Pulmonary Artery Wave Reflection in Dogs With Suspected Pulmonary Hypertension.
    Front Vet Sci. 2021;8:659194.
    PubMed    
    Abstract available

  25. MAEDER MT, Weber L, Buser M, Brenner R, et al
    Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction.
    Front Cardiovasc Med. 2021;8:694240.
    PubMed    
    Abstract available

  26. ZHU F, Zuo L, Hu R, Wang J, et al
    Effect of Immune Cell Infiltration on Occurrence of Pulmonary Hypertension in Pulmonary Fibrosis Patients Based on Gene Expression Profiles.
    Front Med (Lausanne). 2021;8:671617.
    PubMed    
    Abstract available

  27. LOGUE R, Safdar Z
    Chronic Thromboembolic Pulmonary Hypertension Medical Management.
    Methodist Debakey Cardiovasc J. 2021;17:e29-e33.
    PubMed    
    Abstract available

  28. PAN J, Lei L, Zhao C, Wen J, et al
    Clinical characteristics and survival of patients with three major connective tissue diseases associated with pulmonary hypertension: A study from China.
    Exp Ther Med. 2021;22:925.
    PubMed    
    Abstract available

  29. HU XQ, Zhang L
    Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: Implications in drug development.
    Drug Discov Today. 2021 Jul 22. pii: S1359-6446(21)00319.
    PubMed    
    Abstract available

  30. PAPA S, Miotti C, Manzi G, Scoccia G, et al
    Peripheral Arterial Stiffness in Acute Pulmonary Embolism and Pulmonary Hypertension at Short-Term Follow-Up.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  31. ANAND A, Sharma R, Srivastava N, Ramakrishnan S, et al
    J receptor activity in idiopathic pulmonary hypertension and its expected change in the presence of pulmonary bed vasodilators.
    Respir Physiol Neurobiol. 2021 Jul 20:103742. doi: 10.1016/j.resp.2021.103742.
    PubMed    
    Abstract available

  32. DUNCAN MS, Alcorn CW, Freiberg MS, So-Armah K, et al
    Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study.
    Lancet Healthy Longev. 2021;2:e417-e425.
    PubMed    
    Abstract available

  33. SHARMA M, Burns AT, Yap K, Prior DL, et al
    The role of imaging in pulmonary hypertension.
    Cardiovasc Diagn Ther. 2021;11:859-880.
    PubMed    
    Abstract available

  34. CADDIGAN S, Granlund B, Dasgupta A, Chen KH, et al
    PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.
    FASEB J. 2021;35:e21771.
    PubMed    
    Abstract available

  35. SHI J, Liu Z, Li M, Guo J, et al
    Polysaccharide from Potentilla anserina L ameliorate pulmonary edema induced by hypobaric hypoxia in rats.
    Biomed Pharmacother. 2021;139:111669.
    PubMed    
    Abstract available

  36. KIR E, Guven Atici A, Gullu YT, Koksal N, et al
    The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale.
    Int J Clin Pract. 2021;75:e14303.
    PubMed    
    Abstract available

  37. LU X, Zhang J, Liu H, Ma W, et al
    Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.
    Theranostics. 2021;11:5267-5278.
    PubMed    
    Abstract available

  38. AREGULLIN EO, Samuel BP, Girgis R, Vettukattil JJ, et al
    Emergency Use of Occlutech(R) Atrial Flow Regulator Device Facilitates Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation in a Patient With Severe Pulmonary Arterial Hypertension.
    J Intensive Care Med. 2021;36:726-728.
    PubMed    
    Abstract available

  39. QIN S, Predescu D, Carman B, Patel P, et al
    Up-Regulation of the Long Noncoding RNA X-Inactive-Specific Transcript and the Sex Bias in Pulmonary Arterial Hypertension.
    Am J Pathol. 2021;191:1135-1150.
    PubMed    
    Abstract available

  40. LI D, Tang X, Zhu Y, Wei Y, et al
    Pulmonary Artery Size Measurements: A Comparison Study Between Electrocardiogram-Gated and Nonelectrocardiogram-Gated Computed Tomography.
    J Comput Assist Tomogr. 2021;45:415-420.
    PubMed    
    Abstract available

  41. JAIN P, Meredith T, Adji A, Schnegg B, et al
    Spontaneous Oscillatory Left Ventricular-Aortic Uncoupling Under Continuous-Flow Left Ventricular Assist Device Support.
    Circ Heart Fail. 2021;14:e007658.
    PubMed    


  42. XU J, Yang Y, Yang Y, Xiong C, et al
    Identification of Potential Risk Genes and the Immune Landscape of Idiopathic Pulmonary Arterial Hypertension via Microarray Gene Expression Dataset Reanalysis.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  43. LEWIS RA, Billings CG, Hurdman JA, Smith IA, et al
    Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2021;18:34-43.
    PubMed    
    Abstract available

  44. ABU RMILAH A, Fencl R, Watt K, Krowka M, et al
    Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Transplantation. 2020 Jul 6. doi: 10.1097/TP.0000000000003390.
    PubMed    
    Abstract available

  45. UDOVICIC M, Sever M, Kavur L, Loncaric K, et al
    Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal.
    Biomedicines. 2021;9.
    PubMed    
    Abstract available

  46. LESNESKI AL, Vali P, Hardie ME, Lakshminrusimha S, et al
    Randomized Trial of Oxygen Saturation Targets during and after Resuscitation and Reversal of Ductal Flow in an Ovine Model of Meconium Aspiration and Pulmonary Hypertension.
    Children (Basel). 2021;8.
    PubMed    
    Abstract available

  47. FONTES OLIVEIRA M, Oliveira MI, Furtado I, Carvalho L, et al
    External validation of different clinical and echocardiographic scores to distinguish post- from precapillary pulmonary hypertension.
    Echocardiography. 2021 Aug 6. doi: 10.1111/echo.15172.
    PubMed    
    Abstract available

  48. ZHANG Y, Jin Q, Zhao Z, Zhao Q, et al
    Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension.
    Front Cardiovasc Med. 2021;8:699904.
    PubMed    
    Abstract available

  49. SINGH Y, Lakshminrusimha S
    Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2021;48:595-618.
    PubMed    
    Abstract available

  50. PATEL N, Narasimhan B, Bandyopadhyay D, Amreia M, et al
    Impact of Pulmonary Hypertension on In-Hospital Outcomes and 30-Day Readmissions Following Percutaneous Coronary Interventions.
    Mayo Clin Proc. 2021;96:2058-2066.
    PubMed    
    Abstract available

  51. OAKLAND HT, Joseph P
    Sex Differences and the Role of Sex Hormones in Pulmonary Hypertension.
    Clin Chest Med. 2021;42:457-465.
    PubMed    
    Abstract available

  52. AN QY, Wang L, Yuan P, Zhao QH, et al
    Effectiveness and safety of exercise training and rehabilitation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Ann Palliat Med. 2021;10:8134-8146.
    PubMed    
    Abstract available

  53. SAYAD E, Coleman R, Chartan C, Tillman R, et al
    Diagnostic Delays and Characteristics of Pediatric Pulmonary Hypertension Presenting as Syncope.
    Clin Pediatr (Phila). 2021 Aug 5:99228211037190. doi: 10.1177/00099228211037190.
    PubMed    


  54. OTA C, Saito R, Tominaga J, Iwasawa S, et al
    Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Aug 5. doi: 10.1002/ppul.25597.
    PubMed    
    Abstract available

  55. SAUNDERS LC, Hughes PJC, Alabed S, Capener DJ, et al
    Integrated Cardiopulmonary MRI Assessment of Pulmonary Hypertension.
    J Magn Reson Imaging. 2021 Aug 5. doi: 10.1002/jmri.27849.
    PubMed    
    Abstract available

  56. WAN N, Rong W, Zhu W, Jia D, et al
    Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension.
    Ann Transl Med. 2021;9:926.
    PubMed    
    Abstract available

  57. TRAN HB, Maiolo S, Harper R, Zalewski PD, et al
    Dysregulated zinc and sphingosine-1-phosphate signalling in pulmonary hypertension: potential effects by targeting of bone morphogenetic protein receptor type 2 in pulmonary microvessels.
    Cell Biol Int. 2021 Aug 4. doi: 10.1002/cbin.11682.
    PubMed    
    Abstract available

  58. PENG Y, Yang X, Li H, Iqbal M, et al
    Salt-contaminated water inducing pulmonary hypertension and kidney damage by increasing Ang II concentration in broilers.
    Environ Sci Pollut Res Int. 2021 Aug 4. pii: 10.1007/s11356-021-13358.
    PubMed    
    Abstract available

  59. MUKTHAPURAM S, Beebe J, Tkach JA, Arya S, et al
    MRI Assessment of Pulmonary Vascularity in Infants With Congenital Diaphragmatic Hernia: A Novel Tool for Direct Assessment of Severity of Pulmonary Hypertension and Hypoplasia.
    J Pediatr. 2021 Jul 30. pii: S0022-3476(21)00751.
    PubMed    
    Abstract available

  60. UKITA R, Stokes JW, Wu WK, Talackine J, et al
    A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep.
    J Vis Exp. 2021;.
    PubMed    
    Abstract available

  61. LIANG J, Zhu R, Yang Y, Li R, et al
    A predictive model for dilated cardiomyopathy with pulmonary hypertension.
    ESC Heart Fail. 2021 Aug 2. doi: 10.1002/ehf2.13535.
    PubMed    
    Abstract available

  62. WU W, Liu B, Huang M, Hsi DH, et al
    The Role of Four-Dimensional Automatic Right Ventricular Quantification Technology to Determine RV Function and Hemodynamics in Patients With Pulmonary Hypertension Compared With Right Heart Catheterization.
    Front Cardiovasc Med. 2021;8:628610.
    PubMed    
    Abstract available

  63. DEMIR C, Karaman M, Ucan ES, Gokmen AN, et al
    Effects of bevacizumab administration on the hypoxia-induced pulmonary hypertension rat model.
    Turk J Med Sci. 2021 Aug 2. doi: 10.3906/sag-2101.
    PubMed    
    Abstract available

  64. BREINIG S, Dicky O, Ehlinger V, Dulac Y, et al
    Echocardiographic Parameters Predictive of Poor Outcome in Persistent Pulmonary Hypertension of the Newborn (PPHN): Preliminary Results.
    Pediatr Cardiol. 2021 Jul 31. pii: 10.1007/s00246-021-02677.
    PubMed    
    Abstract available

  65. HACHULLA E, Agard C, Allanore Y, Avouac J, et al
    French recommendations for the management of systemic sclerosis.
    Orphanet J Rare Dis. 2021;16.
    PubMed    
    Abstract available

  66. ZUBIETA-CALLEJA G, Zubieta-DeUrioste N
    The Oxygen Transport Triad in High-Altitude Pulmonary Edema: A Perspective from the High Andes.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  67. FRANQUEZA JL, Rosas E, Ioan AM, Durante-Lopez A, et al
    When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2.
    Med Intensiva (Engl Ed). 2021;45:379-380.
    PubMed    


  68. CADDIGAN S, Granlund B, Errington N, Iremonger J, et al
    A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach.
    EBioMedicine. 2021;69:103444.
    PubMed    
    Abstract available

  69. NANGIA S, Thukral A, Chawla D
    Tracheal suction at birth in non-vigorous neonates born through meconium-stained amniotic fluid.
    Cochrane Database Syst Rev. 2021;6:CD012671.
    PubMed    
    Abstract available

  70. MIKAMI T, Naraoka S, Hashimoto A, Doi H, et al
    A case of a giant pulmonary artery aneurysm due to an atrial septal defect with left main coronary artery occlusion.
    Gen Thorac Cardiovasc Surg. 2021;69:1338-1343.
    PubMed    
    Abstract available

  71. SARRAJ-ASIL A, Diez-Villanueva P
    Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2021 Jun 1. pii: S0167-5273(21)00903.
    PubMed    
    Abstract available

  72. HEMELEIN RA, Lajko I, Barath K, Varga J, et al
    Evaluation of cardiopulmonary exercise test in the prediction of disease progression in systemic sclerosis.
    Clin Exp Rheumatol. 2021;39 Suppl 131:94-102.
    PubMed    
    Abstract available

  73. VOLLBACH K, Trepels-Kottek S, Elbracht M, Kurth I, et al
    Alveolar capillary dysplasia without misalignment of pulmonary veins, hyperinflammation, megalocornea and overgrowth - Association with a homozygous 2bp-insertion in LTBP2?
    Eur J Med Genet. 2021;64:104209.
    PubMed    
    Abstract available

  74. SANKAR S, Habib M, Jaafar S, Nagaraja V, et al
    Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.
    Clin Exp Rheumatol. 2021;39 Suppl 131:43-51.
    PubMed    
    Abstract available

  75. VALENT A, Nefzi I, Lopez V, Mirabile C, et al
    Anesthetic management for percutaneous reverse Potts shunt creation in children with refractory idiopathic pulmonary arterial hypertension: a case series.
    Paediatr Anaesth. 2021 Mar 8. doi: 10.1111/pan.14169.
    PubMed    
    Abstract available

  76. DIAS R, Mendes AB, Lages N, Machado H, et al
    Ultrasound-guided fascial plane blocks as unique anesthetic technique for total mastectomy in a covid-19 era: a case report.
    Rev Esp Anestesiol Reanim. 2021;68:408-413.
    PubMed    
    Abstract available

  77. TAHARA M, Sanada K, Morita R, Hawaka H, et al
    Insufficient development of vessels and alveoli in lungs of infants with trisomy 18-Features of pulmonary histopathological findings from lung biopsy.
    Am J Med Genet A. 2021 Jan 4. doi: 10.1002/ajmg.a.62060.
    PubMed    
    Abstract available

  78. LYHNE MD, Kabrhel C, Giordano N, Andersen A, et al
    The echocardiographic ratio tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure predicts short-term adverse outcomes in acute pulmonary embolism.
    Eur Heart J Cardiovasc Imaging. 2021;22:285-294.
    PubMed    
    Abstract available

  79. KAM CW, Ruiz FE
    Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children.
    Pediatr Pulmonol. 2021;56:593-613.
    PubMed    
    Abstract available

  80. HAYABUCHI Y, Homma Y, Kagami S
    Three-dimensional imaging of pulmonary arterial vasa vasorum using optical coherence tomography in patients after bidirectional Glenn and Fontan procedures.
    Eur Heart J Cardiovasc Imaging. 2021;22:941-949.
    PubMed    
    Abstract available

  81. SWIFT AJ, Lu H, Uthoff J, Garg P, et al
    A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.
    Eur Heart J Cardiovasc Imaging. 2021;22:236-245.
    PubMed    
    Abstract available

  82. WELCH CL, Austin ED, Chung WK
    Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.
    Pediatr Pulmonol. 2021;56:614-620.
    PubMed    
    Abstract available

  83. MA T, Ma Z, Zhang X, Zhou F, et al
    Evaluation of Effect of Curcumin on Psychological State of Patients with Pulmonary Hypertension by Magnetic Resonance Image under Deep Learning.
    Contrast Media Mol Imaging. 2021;2021:9935754.
    PubMed    
    Abstract available

  84. ZONG D, Ouyang R
    Pulmonary hypertension complicating mediastinal fibrosis secondary to tuberculosis: A case report and literature review.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46:774-779.
    PubMed    
    Abstract available

  85. KURAKULA K, Hagdorn QAJ, van der Feen DE, Vonk Noordegraaf A, et al
    Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-beta signalling.
    Angiogenesis. 2021 Aug 11. pii: 10.1007/s10456-021-09812.
    PubMed    
    Abstract available

  86. AL ABRI Q, Lu AJ, Ramchandani MK
    Chronic Thromboembolic Pulmonary Hypertension: A Comprehensive Review and Multidisciplinary Approach to Surgical Treatment.
    Methodist Debakey Cardiovasc J. 2021;17:e18-e28.
    PubMed    
    Abstract available

  87. KAMADA H, Kaneyama J, Inoue YY, Noda T, et al
    Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia.
    Sci Rep. 2021;11:16176.
    PubMed    
    Abstract available

  88. LIU J, Deng Y, Fan Z, Xu S, et al
    Construction and analysis of the abnormal lncRNA-miRNA-mRNA network in hypoxic pulmonary hypertension.
    Biosci Rep. 2021 Aug 10. pii: 229497. doi: 10.1042/BSR20210021.
    PubMed    
    Abstract available

  89. LIU HY, Wu YJ, Huang SC, Liu CL, et al
    Experiences with pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension at multiple centers in Taiwan.
    J Formos Med Assoc. 2021 Aug 6. pii: S0929-6646(21)00354.
    PubMed    
    Abstract available

  90. YAMAMOTO K, Tanabe N, Takahashi Y, Naito A, et al
    Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center.
    BMC Pulm Med. 2021;21:260.
    PubMed    
    Abstract available

  91. KARABULUT U, Duygu E, Yilmaz Can Y, Sezer I, et al
    Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy.
    Anatol J Cardiol. 2021;25:590-592.
    PubMed    


  92. WANG F, Zhen Y, Si C, Wang C, et al
    WNT5B promotes vascular smooth muscle cell dedifferentiation via mitochondrial dynamics regulation in chronic thromboembolic pulmonary hypertension.
    J Cell Physiol. 2021 Aug 8. doi: 10.1002/jcp.30543.
    PubMed    
    Abstract available

  93. HINTON M, Eltayeb E, Ghavami S, Dakshinamurti S, et al
    Effect of pulsatile stretch on unfolded protein response in a new model of the pulmonary hypertensive vascular wall.
    Biochem Biophys Rep. 2021;27:101080.
    PubMed    
    Abstract available

  94. LICHTBLAU M, Berlier C, Saxer S, Carta AF, et al
    Acute Hemodynamic Effect of Acetazolamide in Patients With Pulmonary Hypertension Whilst Breathing Normoxic and Hypoxic Gas: A Randomized Cross-Over Trial.
    Front Med (Lausanne). 2021;8:681473.
    PubMed    
    Abstract available

  95. CALE R, Ferreira F, Pereira AR, Saraiva C, et al
    Balloon pulmonary angioplasty protocol in a Portuguese pulmonary hypertension expert center.
    Rev Port Cardiol. 2021 Aug 5. pii: S0870-2551(21)00258.
    PubMed    
    Abstract available

  96. SUZUKI M, Katsuno T, Kawajiri K, Hojo M, et al
    Lung volume recovery and improvement of pulmonary hypertension following surgical repair for Bochdalek hernia.
    BMJ Case Rep. 2021;14.
    PubMed    


  97. BAKER CE, Chalmers BP, Taunton MJ, Maradit Kremers H, et al
    Primary and Revision Total Knee Arthroplasty in Patients With Pulmonary Hypertension: High Perioperative Mortality and Complications.
    J Arthroplasty. 2021 Jul 16. pii: S0883-5403(21)00595.
    PubMed    
    Abstract available

  98. VELAZQUEZ M, Maneiro N, Lareo A, Albarran A, et al
    Selective Segmental Pulmonary Angiography: Anatomical, Technical and Safety Aspects of a Must-Learn Technique in Times of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  99. BALTAZARES-LIPP ME, Aguilera-Velasco A, Aquino-Galvez A, Velazquez-Cruz R, et al
    Evaluating of Red Blood Cell Distribution Width, Comorbidities and Electrocardiographic Ratios as Predictors of Prognosis in Patients with Pulmonary Hypertension.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  100. RALLIDIS LS, Papangelopoulou K, Anthi A, Tsangaris I, et al
    The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  101. MASSON SILVA JB, Tannus Silva DGS, Furtado RG, da Silva Junior CG, et al
    Correlation Between 2D Strain and Classic Echocardiographic Indices in the Diagnosis of Right Ventricular Dysfunction in COPD.
    Int J Chron Obstruct Pulmon Dis. 2021;16:1967-1976.
    PubMed    
    Abstract available

  102. PAL-GHOSH R, Xue D, Warburton R, Hill N, et al
    CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  103. GAHEEN R, El Amrousy D, Hodeib H, Elnemr S, et al
    Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease.
    Eur J Pediatr. 2021 Apr 4. pii: 10.1007/s00431-021-04060.
    PubMed    
    Abstract available

  104. PUISNEY-DAKHLI C, Gubana F, Petit F, Bouchghoul H, et al
    Early prenatal diagnosis of alveolar capillary dysplasia with misalignment of pulmonary veins due to a 16q24.1 deletion.
    Am J Med Genet A. 2021;185:1494-1497.
    PubMed    
    Abstract available

  105. DIDRIKSEN H, Molberg O, Fretheim H, Gude E, et al
    Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Arthritis Rheumatol. 2021;73:1277-1287.
    PubMed    
    Abstract available

  106. BALLARD W 3RD, Dixon B, McEvoy CA, Verma AK, et al
    Pulmonary Arterial Hypertension in Pregnancy.
    Cardiol Clin. 2021;39:109-118.
    PubMed    
    Abstract available

  107. GU X, Wang Y, Wang H, Wu H, et al
    Homology modeling, molecular dynamics and virtual screening of endothelin-A receptor for the treatment of pulmonary arterial hypertension.
    J Biomol Struct Dyn. 2021;39:3912-3923.
    PubMed    
    Abstract available

  108. AL-NAAMANI N, Krowka MJ, Forde KA, Krok KL, et al
    Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
    Hepatology. 2021;73:726-737.
    PubMed    
    Abstract available

  109. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed    
    Abstract available

  110. CRITSER PJ, Evers PD, Schneider K, Hirsch R, et al
    Echocardiography-derived septal curvature correlated with invasive hemodynamics in pediatric pulmonary hypertension.
    J Echocardiogr. 2021 Aug 20. pii: 10.1007/s12574-021-00545.
    PubMed    
    Abstract available

  111. SONG IC, Yeon SH, Lee MW, Ryu H, et al
    Pulmonary hypertension in patients with chronic myeloid leukemia.
    Medicine (Baltimore). 2021;100:e26975.
    PubMed    
    Abstract available

  112. MATUSOV Y, Singh I, Yu YR, Chun HJ, et al
    Chronic Thromboembolic Pulmonary Hypertension: the Bedside.
    Curr Cardiol Rep. 2021;23:147.
    PubMed    
    Abstract available

  113. ALBA GA, Atri D, Darbha S, Singh I, et al
    Chronic Thromboembolic Pulmonary Hypertension: the Bench.
    Curr Cardiol Rep. 2021;23:141.
    PubMed    
    Abstract available

  114. LEI Y, Yang QI, Nie Y, Wan J, et al
    Small-molecule inhibitor LF3 restrains the development of pulmonary hypertension through the Wnt/beta-catenin pathway.
    Acta Biochim Biophys Sin (Shanghai). 2021 Aug 19. pii: 6354945.
    PubMed    
    Abstract available

  115. CHONG CZ, Tay ELW, Sia CH, Poh KK, et al
    Chronic thromboembolic pulmonary hypertension: a review.
    Singapore Med J. 2021;62:318-325.
    PubMed    
    Abstract available

  116. GUTH S, D'Armini AM, Delcroix M, Nakayama K, et al
    Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  117. HAQUE A, Kiely DG, Kovacs G, Thompson AAR, et al
    Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Eur Respir Rev. 2021;30.
    PubMed    
    Abstract available

  118. CAO J, Miao QL, Yang GC, Zhang H, et al
    [The role of FOXF1 and Serotonin transporter in alveolar capillary dysplasia with misalignment of pulmonary veins with differential diagnosis].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:811-813.
    PubMed    


  119. YU H, Ma C, Zhu DL
    [Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxic pulmonary arterial hypertension].
    Sheng Li Xue Bao. 2021;73:646-656.
    PubMed    
    Abstract available

  120. AMGOUD Y, Senbel A, Bouhadoun A, Abdelazeem H, et al
    In search of pulmonary hypertension treatments: Effect of 17beta-estradiol on PGI2 pathway in human pulmonary artery.
    Prostaglandins Leukot Essent Fatty Acids. 2021;172:102321.
    PubMed    
    Abstract available

  121. WILCOX SR, Faridi MK, Camargo CA Jr
    Intensive care unit admission for patients with pulmonary hypertension presenting to U.S. Emergency Departments.
    Am J Emerg Med. 2021;50:237-241.
    PubMed    
    Abstract available

  122. HON JJ, Lang SJ, Roychoudhury D
    Cardiac mass causing pulmonary hypertension: Dilemma resolved with multimodality imaging.
    Respir Med Case Rep. 2021;34:101422.
    PubMed    
    Abstract available

  123. SUMIMOTO K, Taniguchi Y, Fujii H, Miwa K, et al
    Rescue balloon pulmonary angioplasty for life-threatening acute pulmonary embolism on chronic thromboembolic pulmonary hypertension patients.
    Respir Med Case Rep. 2021;33:101415.
    PubMed    
    Abstract available

  124. MULLER J, Lichtblau M, Saxer S, Calendo LR, et al
    Effect of Breathing Oxygen-Enriched Air on Exercise Performance in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction: A Randomized, Placebo-Controlled, Crossover Trial.
    Front Med (Lausanne). 2021;8:692029.
    PubMed    
    Abstract available

  125. TAN R, Li C, Xu C, Wu Q, et al
    Targeting JP2: A New Treatment for Pulmonary Hypertension.
    Oxid Med Cell Longev. 2021;2021:2003446.
    PubMed    
    Abstract available

  126. KIM NH
    Balloon pulmonary angioplasty - welcome to chronic thromboembolic pulmonary hypertension treatment.
    Rev Port Cardiol. 2021 Aug 12. pii: S0870-2551(21)00325.
    PubMed    


  127. MARCETIC D, Samarzija M, Vukic Dugac A, Knezevic J, et al
    Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  128. STOLBERG S, Mudawi D, Dean K, Cheng A, et al
    Investigation and management of pulmonary embolism 1: a probability-based approach.
    Br J Hosp Med (Lond). 2021;82:1-16.
    PubMed    
    Abstract available

  129. STOLBERG S, Mudawi D, Dean K, Cheng A, et al
    Investigation and management of pulmonary embolism 2: specific clinical conditions.
    Br J Hosp Med (Lond). 2021;82:1-6.
    PubMed    
    Abstract available

  130. HOCKSTEIN MA, Haycock K, Wiepking M, Lentz S, et al
    Transthoracic Right Heart Echocardiography for the Intensivist.
    J Intensive Care Med. 2021;36:1098-1109.
    PubMed    
    Abstract available

  131. LENG S, Tan RS, Guo J, Chai P, et al
    Cardiovascular magnetic resonance-assessed fast global longitudinal strain parameters add diagnostic and prognostic insights in right ventricular volume and pressure loading disease conditions.
    J Cardiovasc Magn Reson. 2021;23:38.
    PubMed    
    Abstract available

  132. ALABED S, Saunders L, Garg P, Shahin Y, et al
    Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Magn Reson Imaging. 2021;79:66-75.
    PubMed    
    Abstract available

  133. HOWARD LSGE, He J, Watson GMJ, Huang L, et al
    Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials.
    Ann Am Thorac Soc. 2021;18:981-988.
    PubMed    
    Abstract available

  134. MIYAMOTO K, Nakazato Y, Nakayama M, Yoshihara S, et al
    An atypical type of alveolar capillary dysplasia in a 3-month-old infant.
    Pediatr Int. 2021;63:350-352.
    PubMed    


  135. SREE RAMAN K, Shah R, Stokes M, Walls A, et al
    Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension.
    J Cardiovasc Magn Reson. 2021;23:22.
    PubMed    
    Abstract available

  136. MA H, Liu XF, Qi XQ, Huang YH, et al
    Evaluation of Left Ventricular Diastolic Function by 2-D Speckle Tracking Echocardiography in Patients with Connective Tissue Disease-Associated Pulmonary Artery Hypertension.
    Ultrasound Med Biol. 2021;47:910-918.
    PubMed    
    Abstract available

  137. EL-KHUFFASH A, Rios DR, McNamara PJ
    Toward a Rational Approach to Patent Ductus Arteriosus Trials: Selecting the Population of Interest.
    J Pediatr. 2021;233:11-13.
    PubMed    


  138. CHEN L, Gu YJ, Zhou MY, Cheng L, et al
    Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension.
    Curr Med Chem. 2021;28:4731-4741.
    PubMed    
    Abstract available

  139. KOLAITIS NA, Zamanian RT, de Jesus Perez VA, Badesch DB, et al
    Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2021;18:613-622.
    PubMed    
    Abstract available

  140. ZOU YW, Duan J, Wang XH, Yang HH, et al
    Clinical characteristics and aetiological analysis of 133 patients for pulmonary embolism combined with haemoptysis.
    Clin Respir J. 2021;15:169-176.
    PubMed    
    Abstract available

  141. HRUSTANOVIC-KADIC M, Ziegler C, El-Kersh K
    Palliative Care Perception in Pulmonary Arterial Hypertension: Evaluating the Interaction of PPCI, PAH-SYMPACT Questionnaire, and the REVEAL 2.0 Risk Score.
    Ann Am Thorac Soc. 2021;18:361-364.
    PubMed    


  142. ZHANG L, Zeng XX, Li YM, Chen SK, et al
    Keratin 1 attenuates hypoxic pulmonary artery hypertension by suppressing pulmonary artery media smooth muscle expansion.
    Acta Physiol (Oxf). 2021;231:e13558.
    PubMed    
    Abstract available

  143. BAIRD GL, Walsh T, Aliotta J, Allahua M, et al
    Insights from the Menstrual Cycle in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2021;18:218-228.
    PubMed    
    Abstract available

  144. CONSTANTINE A, Dimopoulos K
    Pulmonary artery denervation for pulmonary arterial hypertension.
    Trends Cardiovasc Med. 2021;31:252-260.
    PubMed    
    Abstract available

  145. MICHALSKI BM, Sorensen EP, Hurst EA, Jones HA, et al
    Postsurgical Hypergranulation and Lymphadenopathy in the Setting of Vasodilator Therapy for Scleroderma-Associated Pulmonary Arterial Hypertension.
    Dermatol Surg. 2021;47:436-437.
    PubMed    


  146. CIRULIS MM, Lahm T
    Editorial commentary: Challenges in the diagnosis and management of pulmonary artery stenosis.
    Trends Cardiovasc Med. 2021;31:185-186.
    PubMed    


  147. DAS P, Acharya S, Prahaladan VM, Kumova OK, et al
    Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  148. CHU X, Ahmadvand N, Zhang JS, Seeger W, et al
    Evidence for Multiple Origins of De Novo Formed Vascular Smooth Muscle Cells in Pulmonary Hypertension: Challenging the Dominant Model of Pre-Existing Smooth Muscle Expansion.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  149. SINGH N, Mullin CJ
    Diagnosis of Pulmonary Hypertension.
    R I Med J (2013). 2021;104:30-35.
    PubMed    
    Abstract available

  150. KAMEDA S, Sera F, Sato K, Kurashige M, et al
    Polycythemia Vera Associated with Pulmonary Hypertension and Diffuse Large B-Cell Lymphoma: A Case Report.
    Am J Case Rep. 2021;22:e932956.
    PubMed    
    Abstract available

  151. NOSSENT EJ, Meijboom LJ, Bogaard HJ, Klok FA, et al
    Chronic thromboembolic pulmonary hypertension anno 2021.
    Curr Opin Cardiol. 2021 Aug 23. pii: 00001573-900000000-98870.
    PubMed    
    Abstract available

  152. ABUSEREWA ST, Selim A, Youssef A, Zolty R, et al
    Role of Selexipag in Chronic Obstructive Pulmonary Disease (COPD) Patients With Out-of-Proportion Pulmonary Hypertension.
    Cureus. 2021;13:e16520.
    PubMed    
    Abstract available

  153. HIGHLAND KB, Crawford R, Classi P, Morrison R, et al
    Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
    Health Qual Life Outcomes. 2021;19:202.
    PubMed    
    Abstract available

  154. DIABA-NUHOHO P, Cour M, Hadebe N, Marais D, et al
    Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension.
    BMC Res Notes. 2021;14:324.
    PubMed    
    Abstract available

  155. DYBOWSKA M, Baranska I, Franczuk M, Skoczylas A, et al
    Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors.
    J Thorac Dis. 2021;13:3988-3997.
    PubMed    
    Abstract available

  156. YANG T, Zhou J, Fang L, Wang M, et al
    Protection function of 18beta-glycyrrhetinic acid on rats with high-altitude pulmonary hypertension based on (1)H NMR metabonomics technology.
    Anal Biochem. 2021 Aug 19:114342. doi: 10.1016/j.ab.2021.114342.
    PubMed    
    Abstract available

  157. OKIYAMA N, Iwasaki R, Fukuzono M, Endo R, et al
    Successful treatment of pulmonary hypertension with immunosuppressive therapy in a case of anti-synthetase syndrome.
    J Dermatol. 2021 Aug 21. doi: 10.1111/1346-8138.16111.
    PubMed    


  158. VOGEL DJ, Brame A, Hanks F, Remmington C, et al
    Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.
    Br J Anaesth. 2021 Jun 8. pii: S0007-0912(21)00354.
    PubMed    


  159. CRISTO ROPERO MJ, Cruz-Utrilla A, Escribano-Subias MP
    Epoprostenol for the treatment of pulmonary arterial hypertension.
    Expert Rev Clin Pharmacol. 2021;14:1005-1013.
    PubMed    
    Abstract available

  160. FLIESSER E, Birnhuber A, Marsh LM, Gschwandtner E, et al
    Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
    J Pathol Clin Res. 2021;7:446-458.
    PubMed    
    Abstract available

  161. QUATREDENIERS M, Mendes-Ferreira P, Santos-Ribeiro D, Nakhleh MK, et al
    Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms.
    Cells. 2021;10.
    PubMed    
    Abstract available

  162. HUANG H, Kong L, Luan S, Qi C, et al
    Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.
    Am J Chin Med. 2021;49:437-459.
    PubMed    
    Abstract available

  163. HULTEN EA, Bradley AJ
    Cardiac Magnetic Resonance Evaluation of Pulmonary Arterial Hypertension: Transforming From Supplementary to Primary Imaging Modality?
    JACC Cardiovasc Imaging. 2021;14:943-946.
    PubMed    


  164. ALABED S, Shahin Y, Garg P, Alandejani F, et al
    Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    JACC Cardiovasc Imaging. 2021;14:931-942.
    PubMed    
    Abstract available

  165. ARVANITAKI A, Giannakoulas G, Triantafyllidou E, Karvounis H, et al
    Nailfold videocapillaroscopy: a novel possible surrogate marker for the evaluation of peripheral microangiopathy in pulmonary arterial hypertension.
    Scand J Rheumatol. 2021;50:85-94.
    PubMed    
    Abstract available

  166. SAHOO S, Li Y, de Jesus D, Sembrat JC, et al
    Notch2 Suppression Mimicking Changes in Human Pulmonary Hypertension Modulates Notch1 and Promotes Endothelial Cell Proliferation.
    Am J Physiol Heart Circ Physiol. 2021 Jul 23. doi: 10.1152/ajpheart.00125.2021.
    PubMed    
    Abstract available

  167. HYE T, Dwivedi P, Li W, Lahm T, et al
    Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021;320:L1025-L1037.
    PubMed    
    Abstract available

  168. KASSA B, Kumar R, Mickael C, Sanders L, et al
    Endothelial Cell PHD2-HIF1alpha-PFKFB3 Contributes to Right Ventricle Vascular Adaptation in Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Aug 4. doi: 10.1152/ajplung.00351.2020.
    PubMed    
    Abstract available

  169. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
    Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients.
    Am J Respir Crit Care Med. 2021 Jan 7. doi: 10.1164/rccm.202005-2023.
    PubMed    


  170. MARON BA, Abman SH, Elliott CG, Frantz RP, et al
    Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
    Am J Respir Crit Care Med. 2021;203:1472-1487.
    PubMed    
    Abstract available

  171. YUAN P, Wu WH, Gong SG, Jiang R, et al
    Impact of circGSAP in Peripheral Blood Mononuclear Cells on Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:1579-1583.
    PubMed    


  172. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159
    PubMed    


  173. KLINGER JR
    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.
    PubMed    


  174. BAUGHMAN RP, Shlobin OA, Gupta R, Engel PJ, et al
    Riociguat for Sarcoidosis Associated Pulmonary Hypertension: Results of a One Year Double Blind, Placebo Controlled Trial.
    Chest. 2021 Aug 4. pii: S0012-3692(21)03613-8. doi: 10.1016/j.chest.2021.07.2162
    PubMed    
    Abstract available

  175. INAMPUDI C, Silverman D, Simon MA, Leary PJ, et al
    Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
    Chest. 2021 Aug 12. pii: S0012-3692(21)03666-7. doi: 10.1016/j.chest.2021.
    PubMed    
    Abstract available

  176. LEOPOLD JA
    Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.
    Circulation. 2021;144:556-558.
    PubMed    


  177. POTUS F, Pauciulo MW, Cook EK, Zhu N, et al
    Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.
    Circulation. 2020 Mar 20. doi: 10.1161/CIRCULATIONAHA.119.044320.
    PubMed    
    Abstract available

  178. MORRELL NW
    Screening asymptomatic BMPR2 mutation carriers: a new frontier for pulmonary hypertension physicians?
    Eur Respir J. 2021;58.
    PubMed    


  179. OLSSON KM, Hoeper MM, Pausch C, Grunig E, et al
    Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01483-2021.
    PubMed    


  180. MONTANI D, Girerd B, Jais X, Laveneziana P, et al
    Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation.
    Eur Respir J. 2021;58.
    PubMed    
    Abstract available

  181. KIELY DG, Condliffe R
    Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow.
    Eur Respir J. 2021;58.
    PubMed    


  182. KAZIMIERCZYK R, Szumowski P, Nekolla SG, Blaszczak P, et al
    Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension.
    Heart. 2020 Jun 10. pii: heartjnl-2020-316741. doi: 10.1136/heartjnl-2020-316741
    PubMed    
    Abstract available

  183. HOIT BD
    Is it time to discard outdated notions of pulmonary hypertension in constrictive pericarditis?
    Heart. 2021 Aug 10. pii: heartjnl-2021-319821. doi: 10.1136/heartjnl-2021-319821
    PubMed    


  184. SCHRANZ D
    Reverse Potts Shunt for Pulmonary Hypertension: Back to a "Fetal" Circulation in Part?
    J Am Coll Cardiol. 2021;78:478-480.
    PubMed    


  185. GRADY RM, Canter MW, Wan F, Shmalts AA, et al
    Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.
    J Am Coll Cardiol. 2021;78:468-477.
    PubMed    
    Abstract available

  186. GELZINIS TA
    Pulmonary Hypertension in 2021: Part I-Definition, Classification, Pathophysiology, and Presentation.
    J Cardiothorac Vasc Anesth. 2021 Jul 8. pii: S1053-0770(21)00572.
    PubMed    
    Abstract available

  187. BENZA RL, Ghofrani HA, Grunig E, Hoeper MM, et al
    Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02399.
    PubMed    
    Abstract available

  188. HOEPER MM, Held M
    Response to Badagliacca et al: Multi-dimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:167-168.
    PubMed    


  189. BADAGLIACCA R, Papa S, Rischard F
    Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:166-167.
    PubMed    


  190. DE PERROT M, Gopalan D, Jenkins D, Lang IM, et al
    Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT.
    J Heart Lung Transplant. 2021 Aug 3. pii: S1053-2498(21)02440.
    PubMed    
    Abstract available

  191. YOUNG K, Sosenko I, Claure N
    Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension.
    Thorax. 2021 Aug 24. pii: thoraxjnl-2021-217476.
    PubMed    


  192. BRYANT A, de Jesus Perez V
    CHK yourself, before you wreck yourself: targeting the DNA damage response in secondary pulmonary hypertension.
    Thorax. 2021 Aug 20. pii: thoraxjnl-2021-217882.
    PubMed    


  193. MIURA K, Katsumata Y, Kawakami T, Ikura H, et al
    Exercise tolerance and quality of life in hemodynamically partially improved patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.
    PLoS One. 2021;16:e0255180.
    PubMed    
    Abstract available

  194. RIENGVIRODKIJ N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
    PLoS One. 2021;16:e0255611.
    PubMed    
    Abstract available

  195. BUTT S, Jeppesen JL, Iversen LV, Fenger M, et al
    Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.
    PLoS One. 2021;16:e0247256.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;